The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-03), Polarean Imaging's 14-Day RSI is 69.63.
The industry rank for Polarean Imaging's 14-Day RSI or its related term are showing as below:
PLLWF's 14-Day RSI is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 47.555
vs PLLWF: 69.63
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Polarean Imaging 14-Day RSI Related Terms
PLLWF vs FOFA, BTCY, LFWD: 14-Day RSI Comparison
For the Medical Devices subindustry, Polarean Imaging's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Polarean Imaging 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Polarean Imaging's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Polarean Imaging's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Polarean Imaging (PLLWF) has a 14-Day RSI of 69.63 as of Jul. 03, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Polarean Imaging and its competitors.
Is Polarean Imaging's 14-Day RSI too high?
Polarean Imaging's current 14-Day RSI is 69.63. The Medical Devices & Instruments industry median 14-Day RSI is 47.56. Polarean Imaging's value of 69.63 is 46.4% above this industry median.
How does Polarean Imaging's 14-Day RSI compare to FOFA and BTCY?
Polarean Imaging's 14-Day RSI of 69.63 can be compared against companies in the Medical Devices & Instruments industry. The industry median 14-Day RSI is 47.56. Polarean Imaging's value of 69.63 is 46.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 47.56, based on 870 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Polarean Imaging's current 14-Day RSI of 69.63 is 46.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Polarean Imaging and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 47.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polarean Imaging's current 14-Day RSI is 69.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polarean Imaging stock overvalued right now?
Polarean Imaging (PLLWF) has a current 14-Day RSI of 69.63. The stock's GF Value™ is $0.04, compared to a current price of $0.01 — trading 83.5% below its estimated fair value. The current 14-Day RSI is 69.63 and 46.4% above the Medical Devices & Instruments industry median of 47.56. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Polarean Imaging (PLLWF), the current 14-Day RSI is 69.63 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment is the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives the majority of its revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service, and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PLLWF has been successfully added to your